SlideShare a Scribd company logo

April 2019 – Medical Cannabis and Colorectal Cancer Webinar

There are countless questions when it comes to medical cannabis and colorectal cancer: How can it help? How do you get it? Are there drug interactions with chemo? What are the side effects? Is it legal where I live?

1 of 51
Download to read offline
Clearing the Air: The Role of Medical
Marijuana in Cancer Patients
TODAY’S WEBINAR
 SPEAKER(S)
 Lisa M. Holle, PharmD, BCOP, FHOPA
 QUESTIONS
 Ask a question in the panel on the RIGHT SIDE of your
screen
 WEBINAR ARCHIVE
 FightCRC.org/webinar
 TWEET ALONG
 Follow along via Twitter – use the hashtag #CRCWebinar
RESOURCE
S
TABOO-TY PODCAST MINI MAGAZINES CLINICAL TRIAL FINDER
FIGHTCOLORECTALCANCER
DISCLAIMER
The information and services provided
by Fight Colorectal Cancer are for
general informational purposes only.
The information and services are not
intended to be substitutes for
professional medical advice,
diagnoses or treatment.
If you are ill, or suspect that you are
ill, see a doctor immediately. In an
emergency, call 911 or go to the
nearest emergency room.
Fight Colorectal Cancer never
recommends or endorses any specific
physicians, products or treatments for
any condition.
LisaM.Holle,PharmD,BCOP,
FHOPA
Bio: Dr. Holle is an Associate Clinical Professor of Pharmacy Practice
in the Department of Pharmacy Practice at the UConn School of
Medicine. Her current research interests include those which
evaluate the impact of oncology pharmacy practice services on
patient care, adherence to and patient education/understanding of
appropriate use of orally administered oncology medications.
Ongoing and future projects will focus on the patient-related
outcomes of oncology pharmacy practice care within a team-based
approach and pharmacist-led education and cancer risk-
assessment/screening in the community pharmacy setting. Past
research has included the impact of drug shortages on cancer care;
collaborative cancer therapy and supportive care clinical trials in the
hematopoietic stem cell and oncology setting; and quality
improvement research related to oncology medication safety.
Clearing the Air:
The Role of Medical Marijuana in
Cancer Patients
Lisa M. Holle, PharmD, BCOP, FHOPA
Associate Clinical Professor, School of Pharmacy
Associate Professor, School of Medicine
lisa.holle@uconn.edu

Recommended

April 2019 - Medical Cannabis and Colorectal Cancer Webinar
April 2019 - Medical Cannabis and Colorectal Cancer WebinarApril 2019 - Medical Cannabis and Colorectal Cancer Webinar
April 2019 - Medical Cannabis and Colorectal Cancer WebinarFight Colorectal Cancer
 
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?
Medical Marijuana - Does it Have a Role in the Treatment of Cancer Patients?Canadian Cancer Survivor Network
 
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...
Clinical Trials, Emerging New Drugs and Future Concepts in the Treatment of L...Dana-Farber Cancer Institute
 
Clinical Trials for Metastatic Triple-Negative Breast Cancer
Clinical Trials for Metastatic Triple-Negative Breast CancerClinical Trials for Metastatic Triple-Negative Breast Cancer
Clinical Trials for Metastatic Triple-Negative Breast CancerDana-Farber Cancer Institute
 
JOURNAL CLUB BREAST CANCER
JOURNAL CLUB BREAST CANCERJOURNAL CLUB BREAST CANCER
JOURNAL CLUB BREAST CANCERMeriam Khalil
 
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...Dana-Farber Cancer Institute
 
Nick chen ppt presentation metronomic chemotherapy 2015
Nick chen   ppt presentation metronomic chemotherapy 2015Nick chen   ppt presentation metronomic chemotherapy 2015
Nick chen ppt presentation metronomic chemotherapy 2015CNPS, LLC
 
Dr arun Triple Negative Breast cancer Presentation
Dr arun Triple Negative Breast cancer PresentationDr arun Triple Negative Breast cancer Presentation
Dr arun Triple Negative Breast cancer PresentationArun Shahi MD,MPH
 

More Related Content

What's hot

Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerDana-Farber Cancer Institute
 
Should triple negative breast cancer (tnbc) subtype
Should triple negative breast cancer (tnbc) subtypeShould triple negative breast cancer (tnbc) subtype
Should triple negative breast cancer (tnbc) subtypeEreny Samwel
 
Product Visual Guide
Product Visual GuideProduct Visual Guide
Product Visual GuideManas Tandon
 
Hr+ her2 neu mbc
Hr+ her2 neu   mbcHr+ her2 neu   mbc
Hr+ her2 neu mbcmadurai
 
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...Breast Health Collaborative of Texas
 
What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...
What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...
What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...Dana-Farber Cancer Institute
 
Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)
Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)
Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)Nelson Origa
 
Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Dana-Farber Cancer Institute
 

What's hot (19)

Clinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast CancerClinical Trials for Metastatic HER2-positive Breast Cancer
Clinical Trials for Metastatic HER2-positive Breast Cancer
 
Medical Cannabis in Cancer Treatment
Medical Cannabis in Cancer TreatmentMedical Cannabis in Cancer Treatment
Medical Cannabis in Cancer Treatment
 
CAREtemplate-English
CAREtemplate-EnglishCAREtemplate-English
CAREtemplate-English
 
What's Hot in Breast Cancer Treatment
What's Hot in Breast Cancer TreatmentWhat's Hot in Breast Cancer Treatment
What's Hot in Breast Cancer Treatment
 
Targeting Advanced Triple-Negative Breast Cancer
Targeting Advanced Triple-Negative Breast CancerTargeting Advanced Triple-Negative Breast Cancer
Targeting Advanced Triple-Negative Breast Cancer
 
Should triple negative breast cancer (tnbc) subtype
Should triple negative breast cancer (tnbc) subtypeShould triple negative breast cancer (tnbc) subtype
Should triple negative breast cancer (tnbc) subtype
 
Product Visual Guide
Product Visual GuideProduct Visual Guide
Product Visual Guide
 
Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Onco...
Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Onco...Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Onco...
Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Onco...
 
Hr+ her2 neu mbc
Hr+ her2 neu   mbcHr+ her2 neu   mbc
Hr+ her2 neu mbc
 
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
A Researcher's Perspective: Myths & Facts about Triple Negative Breast Cancer...
 
What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...
What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...
What's New in Metastatic Research and Clinical Trials: ER Positive and Triple...
 
What's New in Treatment of ER+ Breast Cancer?
What's New in Treatment of ER+ Breast Cancer?What's New in Treatment of ER+ Breast Cancer?
What's New in Treatment of ER+ Breast Cancer?
 
What Is a Phase I Clinical Trial?
What Is a Phase I Clinical Trial?What Is a Phase I Clinical Trial?
What Is a Phase I Clinical Trial?
 
t 2006
t 2006t 2006
t 2006
 
Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)
Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)
Akynzeo+a+better+or+bitter+pill+for+the+prevention+of+cinv (1)
 
Management of menopausal symptoms in breast cancer survivors
Management of menopausal symptoms in breast cancer survivorsManagement of menopausal symptoms in breast cancer survivors
Management of menopausal symptoms in breast cancer survivors
 
Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...Research in the Program for Young Women with Breast Cancer: Past, Present and...
Research in the Program for Young Women with Breast Cancer: Past, Present and...
 
Healthy Living After A Breast Cancer Diagnosis
Healthy Living After A Breast Cancer DiagnosisHealthy Living After A Breast Cancer Diagnosis
Healthy Living After A Breast Cancer Diagnosis
 
Immunotherapy for Breast Cancer
Immunotherapy for Breast CancerImmunotherapy for Breast Cancer
Immunotherapy for Breast Cancer
 

Similar to April 2019 – Medical Cannabis and Colorectal Cancer Webinar

Medical Marijuana
Medical MarijuanaMedical Marijuana
Medical Marijuanataha_801
 
012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adults012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adultsGeorgi Daskalov
 
Marijuana for Medical Purposes Regulation - What Do I Need to Know?
Marijuana for Medical Purposes Regulation - What Do I Need to Know?Marijuana for Medical Purposes Regulation - What Do I Need to Know?
Marijuana for Medical Purposes Regulation - What Do I Need to Know?Canadian Cancer Survivor Network
 
Marijuana: Medicinal Use and Legalization Ramifications
Marijuana: Medicinal Use and Legalization RamificationsMarijuana: Medicinal Use and Legalization Ramifications
Marijuana: Medicinal Use and Legalization RamificationsSpectrum Health System
 
Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Joost Burger
 
Drug rediscovery: Clash between old and older ?
Drug rediscovery: Clash between old and older ?Drug rediscovery: Clash between old and older ?
Drug rediscovery: Clash between old and older ?4PharmaAndHealth
 
Cannabinoid and Harm Reduction among cannabis users
Cannabinoid and Harm Reduction among cannabis users Cannabinoid and Harm Reduction among cannabis users
Cannabinoid and Harm Reduction among cannabis users Sébastien Béguerie
 
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...Dana-Farber Cancer Institute
 
Endocrine_therapy.ppt
Endocrine_therapy.pptEndocrine_therapy.ppt
Endocrine_therapy.pptDoQuyenPhan1
 
Comprehensive Report on The Cannabis Extract Movement
Comprehensive Report on The Cannabis Extract MovementComprehensive Report on The Cannabis Extract Movement
Comprehensive Report on The Cannabis Extract MovementTheHempSolution
 
THC and CBD Features comparison - Hemprove
THC and CBD Features comparison - HemproveTHC and CBD Features comparison - Hemprove
THC and CBD Features comparison - HemproveHemprove
 
Hooks_FinalProposal
Hooks_FinalProposalHooks_FinalProposal
Hooks_FinalProposalSarah Hooks
 
Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...
Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...
Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...European School of Oncology
 

Similar to April 2019 – Medical Cannabis and Colorectal Cancer Webinar (20)

Cannabis.pptx
Cannabis.pptxCannabis.pptx
Cannabis.pptx
 
Medical Marijuana
Medical MarijuanaMedical Marijuana
Medical Marijuana
 
Marijuana as medicine
Marijuana as medicineMarijuana as medicine
Marijuana as medicine
 
012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adults012012 v156 i2 cytisine increased smoking cessation in adults
012012 v156 i2 cytisine increased smoking cessation in adults
 
Marijuana for Medical Purposes Regulation - What Do I Need to Know?
Marijuana for Medical Purposes Regulation - What Do I Need to Know?Marijuana for Medical Purposes Regulation - What Do I Need to Know?
Marijuana for Medical Purposes Regulation - What Do I Need to Know?
 
Vitality bio-ppt-v15-december-2016
Vitality bio-ppt-v15-december-2016Vitality bio-ppt-v15-december-2016
Vitality bio-ppt-v15-december-2016
 
MJ presentation eav 032615
MJ presentation eav 032615MJ presentation eav 032615
MJ presentation eav 032615
 
Marijuana: Medicinal Use and Legalization Ramifications
Marijuana: Medicinal Use and Legalization RamificationsMarijuana: Medicinal Use and Legalization Ramifications
Marijuana: Medicinal Use and Legalization Ramifications
 
Transforming Treatment in Ovarian Cancer
Transforming Treatment in Ovarian CancerTransforming Treatment in Ovarian Cancer
Transforming Treatment in Ovarian Cancer
 
The New Immuno-Oncology Era in Early-Stage Bladder Cancer: Readying the Moder...
The New Immuno-Oncology Era in Early-Stage Bladder Cancer: Readying the Moder...The New Immuno-Oncology Era in Early-Stage Bladder Cancer: Readying the Moder...
The New Immuno-Oncology Era in Early-Stage Bladder Cancer: Readying the Moder...
 
Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)Dia philadelphia juni 2012 (2) (1)
Dia philadelphia juni 2012 (2) (1)
 
Drug rediscovery: Clash between old and older ?
Drug rediscovery: Clash between old and older ?Drug rediscovery: Clash between old and older ?
Drug rediscovery: Clash between old and older ?
 
Medical Marijuana in Canada - January 22, 2015
Medical Marijuana in Canada -  January 22, 2015Medical Marijuana in Canada -  January 22, 2015
Medical Marijuana in Canada - January 22, 2015
 
Cannabinoid and Harm Reduction among cannabis users
Cannabinoid and Harm Reduction among cannabis users Cannabinoid and Harm Reduction among cannabis users
Cannabinoid and Harm Reduction among cannabis users
 
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...What’s New in Biology, Treatment  and Clinical Trials for Metastatic Triple-N...
What’s New in Biology, Treatment and Clinical Trials for Metastatic Triple-N...
 
Endocrine_therapy.ppt
Endocrine_therapy.pptEndocrine_therapy.ppt
Endocrine_therapy.ppt
 
Comprehensive Report on The Cannabis Extract Movement
Comprehensive Report on The Cannabis Extract MovementComprehensive Report on The Cannabis Extract Movement
Comprehensive Report on The Cannabis Extract Movement
 
THC and CBD Features comparison - Hemprove
THC and CBD Features comparison - HemproveTHC and CBD Features comparison - Hemprove
THC and CBD Features comparison - Hemprove
 
Hooks_FinalProposal
Hooks_FinalProposalHooks_FinalProposal
Hooks_FinalProposal
 
Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...
Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...
Gene Profiling in Clinical Oncology - Slide 12 - N. Liebermann - But can my h...
 

More from Fight Colorectal Cancer

Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.Fight Colorectal Cancer
 
Managing the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal CancerManaging the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal CancerFight Colorectal Cancer
 
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNABiomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNAFight Colorectal Cancer
 
Coping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer DiagnosisCoping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer DiagnosisFight Colorectal Cancer
 
Colorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinarColorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinarFight Colorectal Cancer
 
Research Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer WebinarResearch Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer WebinarFight Colorectal Cancer
 
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarMay 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarFight Colorectal Cancer
 

More from Fight Colorectal Cancer (20)

Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.Colorectal Cancer Screening Trends in the U.S.
Colorectal Cancer Screening Trends in the U.S.
 
August 2020 Webinar Slides
August 2020 Webinar SlidesAugust 2020 Webinar Slides
August 2020 Webinar Slides
 
July 2020 webinar slides
July 2020 webinar slidesJuly 2020 webinar slides
July 2020 webinar slides
 
Managing the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal CancerManaging the Digestive Side Effects of Colorectal Cancer
Managing the Digestive Side Effects of Colorectal Cancer
 
Maine’s CRC Policy Story
Maine’s CRC Policy StoryMaine’s CRC Policy Story
Maine’s CRC Policy Story
 
Indiana’s CRC Policy Story
Indiana’s CRC Policy StoryIndiana’s CRC Policy Story
Indiana’s CRC Policy Story
 
Kentucky’s CRC Policy Story Webinar
Kentucky’s CRC Policy Story WebinarKentucky’s CRC Policy Story Webinar
Kentucky’s CRC Policy Story Webinar
 
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNABiomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
Biomarkers: Next Generation Sequencing and Updates on NTRK and ctDNA
 
Coping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer DiagnosisCoping After a Colorectal Cancer Diagnosis
Coping After a Colorectal Cancer Diagnosis
 
Colorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinarColorectal Cancer Treatment Side Effects of the Skin webinar
Colorectal Cancer Treatment Side Effects of the Skin webinar
 
GI ASCO 2020 Recap Webinar
GI ASCO 2020 Recap WebinarGI ASCO 2020 Recap Webinar
GI ASCO 2020 Recap Webinar
 
Conversations About End-of-Life Webinar
Conversations About End-of-Life WebinarConversations About End-of-Life Webinar
Conversations About End-of-Life Webinar
 
Clinical Trial Finder Webinar
Clinical Trial Finder WebinarClinical Trial Finder Webinar
Clinical Trial Finder Webinar
 
Palliative Care 101 Webinar
Palliative Care 101 WebinarPalliative Care 101 Webinar
Palliative Care 101 Webinar
 
Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar Cancer-Related Fatigue Webinar
Cancer-Related Fatigue Webinar
 
August 2019 - Recurrence: What now?
August 2019 - Recurrence: What now?August 2019 - Recurrence: What now?
August 2019 - Recurrence: What now?
 
Research Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer WebinarResearch Trends in Exercise and Colorectal Cancer Webinar
Research Trends in Exercise and Colorectal Cancer Webinar
 
Post ASCO Webinar 2019
Post ASCO Webinar 2019Post ASCO Webinar 2019
Post ASCO Webinar 2019
 
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarMay 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy Webinar
 
May 2019 – Cancer and Trauma Webinar
May 2019 – Cancer and Trauma Webinar May 2019 – Cancer and Trauma Webinar
May 2019 – Cancer and Trauma Webinar
 

Recently uploaded

Cell :Structure & Functions for Medical and Health allied Students
Cell :Structure & Functions for Medical and Health allied StudentsCell :Structure & Functions for Medical and Health allied Students
Cell :Structure & Functions for Medical and Health allied StudentsRajendra Dev Bhatt
 
Arts-Focused Approaches to Public Health Communications
Arts-Focused Approaches to Public Health CommunicationsArts-Focused Approaches to Public Health Communications
Arts-Focused Approaches to Public Health Communicationskatiequigley33
 
Yantra used in Rasashastra: Equipments and Machineries
Yantra used in Rasashastra: Equipments and MachineriesYantra used in Rasashastra: Equipments and Machineries
Yantra used in Rasashastra: Equipments and MachineriesAparnaNandakumar12
 
STUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptx
STUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptxSTUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptx
STUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptxDr. Aniket Shilwant
 
GROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.ppt
GROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.pptGROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.ppt
GROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.pptDr Vinay KV Shetty
 
Fetal and Neonatal Physiology - Dr Faiza.pdf
Fetal and Neonatal Physiology - Dr Faiza.pdfFetal and Neonatal Physiology - Dr Faiza.pdf
Fetal and Neonatal Physiology - Dr Faiza.pdfMedicoseAcademics
 
PTERYGIUM ,clinical picture and its management.pptx
PTERYGIUM ,clinical picture and its management.pptxPTERYGIUM ,clinical picture and its management.pptx
PTERYGIUM ,clinical picture and its management.pptxvideosfildr
 
Finger Clubbing by Dr. Samuel2 Alawode.pptx
Finger Clubbing by Dr. Samuel2 Alawode.pptxFinger Clubbing by Dr. Samuel2 Alawode.pptx
Finger Clubbing by Dr. Samuel2 Alawode.pptxAlawode Samuel2
 
Physiology of Pituitary gland and its hormones -3.pptx
Physiology of Pituitary gland and its hormones -3.pptxPhysiology of Pituitary gland and its hormones -3.pptx
Physiology of Pituitary gland and its hormones -3.pptxSai Sailesh Kumar Goothy
 
Anatomy of Female Reproductive System.pptx
Anatomy of Female Reproductive System.pptxAnatomy of Female Reproductive System.pptx
Anatomy of Female Reproductive System.pptxMathew Joseph
 
Tuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, PrayagrajTuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, PrayagrajSurabhi Srivastava
 
RASASHALA IN ACCORDANCE WITH GMP....pptx
RASASHALA IN ACCORDANCE WITH GMP....pptxRASASHALA IN ACCORDANCE WITH GMP....pptx
RASASHALA IN ACCORDANCE WITH GMP....pptxDr. Anusha Baseganni
 
gynae pcd pharma franchise - Solace Biotech Limited
gynae pcd pharma franchise -  Solace Biotech Limitedgynae pcd pharma franchise -  Solace Biotech Limited
gynae pcd pharma franchise - Solace Biotech LimitedSBL DIGITAL
 
(DENGUE).pptx Department of Physiotherapy, SHUATS, Prayagraj
(DENGUE).pptx Department of Physiotherapy, SHUATS, Prayagraj(DENGUE).pptx Department of Physiotherapy, SHUATS, Prayagraj
(DENGUE).pptx Department of Physiotherapy, SHUATS, PrayagrajSurabhi Srivastava
 
Typhoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, PrayagrajTyphoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, PrayagrajSurabhi Srivastava
 
Shodhanagha snehapana.pptx Dr Akshay Shetty
Shodhanagha snehapana.pptx Dr Akshay ShettyShodhanagha snehapana.pptx Dr Akshay Shetty
Shodhanagha snehapana.pptx Dr Akshay ShettyAkshay Shetty
 
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdfGuía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdfJuniorAlexanderCasti
 

Recently uploaded (20)

Cell :Structure & Functions for Medical and Health allied Students
Cell :Structure & Functions for Medical and Health allied StudentsCell :Structure & Functions for Medical and Health allied Students
Cell :Structure & Functions for Medical and Health allied Students
 
Arts-Focused Approaches to Public Health Communications
Arts-Focused Approaches to Public Health CommunicationsArts-Focused Approaches to Public Health Communications
Arts-Focused Approaches to Public Health Communications
 
Yantra used in Rasashastra: Equipments and Machineries
Yantra used in Rasashastra: Equipments and MachineriesYantra used in Rasashastra: Equipments and Machineries
Yantra used in Rasashastra: Equipments and Machineries
 
STUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptx
STUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptxSTUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptx
STUDY OF BASIC FUNDAMENTALS OF URINE FORMATION PHYSIOLOGY.pptx
 
A Comprehensive Fatty Liver Program .pptx
A Comprehensive Fatty Liver Program .pptxA Comprehensive Fatty Liver Program .pptx
A Comprehensive Fatty Liver Program .pptx
 
GROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.ppt
GROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.pptGROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.ppt
GROSS ANATOMY OF CAECUM & APPENDIX DR VKVS.ppt
 
Pancreatic Cancer an Overview - CCSN 2024-02-29
Pancreatic Cancer an Overview - CCSN 2024-02-29Pancreatic Cancer an Overview - CCSN 2024-02-29
Pancreatic Cancer an Overview - CCSN 2024-02-29
 
Fetal and Neonatal Physiology - Dr Faiza.pdf
Fetal and Neonatal Physiology - Dr Faiza.pdfFetal and Neonatal Physiology - Dr Faiza.pdf
Fetal and Neonatal Physiology - Dr Faiza.pdf
 
PTERYGIUM ,clinical picture and its management.pptx
PTERYGIUM ,clinical picture and its management.pptxPTERYGIUM ,clinical picture and its management.pptx
PTERYGIUM ,clinical picture and its management.pptx
 
Finger Clubbing by Dr. Samuel2 Alawode.pptx
Finger Clubbing by Dr. Samuel2 Alawode.pptxFinger Clubbing by Dr. Samuel2 Alawode.pptx
Finger Clubbing by Dr. Samuel2 Alawode.pptx
 
Physiology of Pituitary gland and its hormones -3.pptx
Physiology of Pituitary gland and its hormones -3.pptxPhysiology of Pituitary gland and its hormones -3.pptx
Physiology of Pituitary gland and its hormones -3.pptx
 
Anatomy of Female Reproductive System.pptx
Anatomy of Female Reproductive System.pptxAnatomy of Female Reproductive System.pptx
Anatomy of Female Reproductive System.pptx
 
Tuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, PrayagrajTuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
Tuberculosis .pptx Department of Physiotherapy, SHUATS, Prayagraj
 
RASASHALA IN ACCORDANCE WITH GMP....pptx
RASASHALA IN ACCORDANCE WITH GMP....pptxRASASHALA IN ACCORDANCE WITH GMP....pptx
RASASHALA IN ACCORDANCE WITH GMP....pptx
 
gynae pcd pharma franchise - Solace Biotech Limited
gynae pcd pharma franchise -  Solace Biotech Limitedgynae pcd pharma franchise -  Solace Biotech Limited
gynae pcd pharma franchise - Solace Biotech Limited
 
(DENGUE).pptx Department of Physiotherapy, SHUATS, Prayagraj
(DENGUE).pptx Department of Physiotherapy, SHUATS, Prayagraj(DENGUE).pptx Department of Physiotherapy, SHUATS, Prayagraj
(DENGUE).pptx Department of Physiotherapy, SHUATS, Prayagraj
 
eye disorders .pptx
eye disorders .pptxeye disorders .pptx
eye disorders .pptx
 
Typhoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, PrayagrajTyphoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
Typhoid.pptx Department of Physiotherapy, SHUATS, Prayagraj
 
Shodhanagha snehapana.pptx Dr Akshay Shetty
Shodhanagha snehapana.pptx Dr Akshay ShettyShodhanagha snehapana.pptx Dr Akshay Shetty
Shodhanagha snehapana.pptx Dr Akshay Shetty
 
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdfGuía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
Guía síndrome coronario agudo.pdf Guía síndrome coronario agudo.pdf
 

April 2019 – Medical Cannabis and Colorectal Cancer Webinar

  • 1. Clearing the Air: The Role of Medical Marijuana in Cancer Patients
  • 2. TODAY’S WEBINAR  SPEAKER(S)  Lisa M. Holle, PharmD, BCOP, FHOPA  QUESTIONS  Ask a question in the panel on the RIGHT SIDE of your screen  WEBINAR ARCHIVE  FightCRC.org/webinar  TWEET ALONG  Follow along via Twitter – use the hashtag #CRCWebinar
  • 3. RESOURCE S TABOO-TY PODCAST MINI MAGAZINES CLINICAL TRIAL FINDER
  • 4. FIGHTCOLORECTALCANCER DISCLAIMER The information and services provided by Fight Colorectal Cancer are for general informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnoses or treatment. If you are ill, or suspect that you are ill, see a doctor immediately. In an emergency, call 911 or go to the nearest emergency room. Fight Colorectal Cancer never recommends or endorses any specific physicians, products or treatments for any condition.
  • 5. LisaM.Holle,PharmD,BCOP, FHOPA Bio: Dr. Holle is an Associate Clinical Professor of Pharmacy Practice in the Department of Pharmacy Practice at the UConn School of Medicine. Her current research interests include those which evaluate the impact of oncology pharmacy practice services on patient care, adherence to and patient education/understanding of appropriate use of orally administered oncology medications. Ongoing and future projects will focus on the patient-related outcomes of oncology pharmacy practice care within a team-based approach and pharmacist-led education and cancer risk- assessment/screening in the community pharmacy setting. Past research has included the impact of drug shortages on cancer care; collaborative cancer therapy and supportive care clinical trials in the hematopoietic stem cell and oncology setting; and quality improvement research related to oncology medication safety.
  • 6. Clearing the Air: The Role of Medical Marijuana in Cancer Patients Lisa M. Holle, PharmD, BCOP, FHOPA Associate Clinical Professor, School of Pharmacy Associate Professor, School of Medicine lisa.holle@uconn.edu
  • 7. What is Medical Marijuana? • Cannabis – produced from Cannabis sativa/indica/ruderalis – Marijuana – flower/leaves – Hashish – blocks of resin • Cannabinoids – exhibit drug-like effects – Endogenous cannabinoids – Phytocannabinoids – produced by Cannabis sativa and indica species – Synthetic cannabinoids • Medical marijuana – use of phytocannabinoids or synthetic cannabinoids Parmer J, et al. Res Soc Admin Pharm. 2015. [published ahead of print]
  • 8. Medical Marijuana History Western Medicine Marihuana Tax Act Narcotic Schedule I Compass- ionate Use Synthetic drugs Medical Use CBD Oral Solution FDA approved CBD, cannabidiol. National Cancer Institute. Available at: http://www.cancer.gov/about- cancer/treatment/cam/hp/cannabis-pdq#section/_5 . Accessed March 24, 2019. 1840s 1937 1951 1970 1971-1990 1986 1980s-90s 2018
  • 9. Medical Marijuana. ProCon.org. Available at: https://medicalmarijuana.procon.org/view.resource.php?resourceID=000881. Accessed March 24, 2019.
  • 10. Differences in State Medical Marijuana Programs • Laws very greatly • Approved conditions • Possession amounts/cultivation allowed • Registration processes • Allow dispensaries (does not allow dispensaries OR, NE, MI, HI) • Pharmacist oversight of dispensaries (AK, CT, MN, NY, OK, PA); marijuana pharmacies (LA, UT) • Specify conditions in which it can be used • Recognize patients from other status (AZ, AR, ME, MI, NE, NH, OK, RI) Medical Marijuana. ProConorg. Available at: https://medicalmarijuana.procon.org/view.resource.php?resourceID=000881. Accessed 5 Jan 2019.
  • 11. How Medical Marijuana Works In the Body
  • 12. What Are The Different Types Recreated from Turgeman I, et al. Expert Opin Invest Drugs. 2018 (in press): DOI: 10.1080/13543784.2019.1561859. Cannabis Plant (sativa, indica, ruderalis) Phytocannabinoid THC CBD Cannabinol Tetrahydro- cannabivarin Cannabigerol Terpenoid Limonen Terinolen Pinene Flavonoid Canna- flavin A Orientin Quercetin • Anandamide • 2-arachidononyl- gylcerol Endogenous Cannabinoid System • Classical •Nabilone •Dronabinol • Nonclassical •JWH-018 •Methanadmide •AM4030 Synthetic Cannabinoids
  • 13. What Effects Does it Have? Recreated from Turgeman I, et al. Expert Opin Invest Drugs. 2018 (in press): DOI: 10.1080/13543784.2019.1561859. • Cannabinoids in marijuana – Delta-9- tetrahydrocannabidiol (THC) – Cannabidiol (CBD)
  • 14. Biologic Effects Guzman M. N Rev Cancer. 2003;3:745-755. CB1 – central and peripheral neurons; CB2 – immune system.
  • 15. How You Can Take Medical Marijuana Bowels DW, et al. Crit Rev Oncol/Hematol. 2012;83:1-10; Kramer JL. CA Cancer J Clin. 2015;65:109-122. • Inhalation • Oral • Rectal • Sublingual • Transdermal • Ophthalmic • Intrathecal • Intravenous
  • 16. What About CBD Oil? • 2014 United States Farm Act – Classified industrial hemp as containing < 0.3% THC – Allowed to be sold in all 50 states – Other ingredients? – Regulated?
  • 17. FDA Approved Synthetic Products • Dronabinol (Marinol®) – Synthetic THC – CINV failing other treatments – Weight loss and anorexia with AIDS – Schedule III • Nabilone (Cesamet®) – Synthetic THC-mimetic – CINV failing other treatments – Schedule II CINV, chemotherapy-induced nausea and vomiting; FDA, US Food and Drug Administration. Bowels DW, et al. Crit Rev Oncol/Hematol. 2012;83:1-10; Kramer JL. CA Cancer J Clin. 2015;65:109-122.
  • 18. Approved Oral Products Nabiximols (Sativex®) • THC + CBD extract • Multiple sclerosis and cancer pain • Not available in US Cannabidiol (Epidiolex®) • Plant-derived oral CBD solution • June 2018: FDA approved • Treatment of seizures associated with Lenox- Gastaut syndrome or Dravet syndrome in patients > 2 years • September 2018 – DEA Schedule 5 • CT: Schedule 2 FDA, US Food and Drug Administration Approved. Drug Enforcement Agency. Available at: https://www.dea.gov/press-releases/2018/09/27/fda-approved-drug- epidiolex-placed-schedule-v-controlled-substance-act. Accessed March 24, 2019.
  • 19. How Your Body Absorbs It Dosage Form Absorption Peak Level Factors Impacting Absorption Bioavailability Inhalation Quick fast, rapid delivery to brain 22 min Depth of inhalation, frequency of puffs, breath hold Varies: 2-56% Heavy: 23-27% Occasional: 10-14% Oral Slow 1-2 h; up to 8 h Degradation of drug in stomach and first-pass 10-20% Oral-mucosal/ buccal Fast 30 min High first-pass metabolism 10-20% Rectal Fast 15 min Low first-pass metabolism 20-40% Transcutaneous Slow 2 hr; up to 48 h Transport across skin layers; no first-pass metabolism 10% Oberbarnscheidt T, et al. J Addict Res Ther. 2017;S11:012. Crosses placenta and into breast milk.
  • 20. How Your Body Digests It • Metabolism – Liver metabolism – Other metabolism: brain, intestine, lung • Drug Interactions – Medications that cause drowsiness/dizziness – Many potential interactions CBD, cannabidiol; CYP450, cytochrome P450; THC, delta-9-tetrahydrocannabinoid. MacCallum CA, et al. Eur J Inter Med. 2018;49:12-19; Epidiolex [package insert]. Carlsbad, CA: Greenwich Biosciences, Inc: 2018.
  • 23. Cancer Treatment • Multiple pathways explored in preclinical models • Phase I refractory glioblastoma • Case report: astrocytomas • Case report: acute lymphoblastic leukemia • In progress – Phase II placebo-controlled THC:CBD preparation + temozolomide in glioblastoma – safe; survival advantage – Phase II nabiximols + temozolomide in glioblastoma – Two phase I dexananibol – advanced solid tumors and brain cancers – Retrospective review of immunotherapy + cannabis effects CBD, cannabidiol; THC, delta-9-tetrahydrocannabinoid. Turgeman I, et al. Expert Opin Invest Drugs. 2018 (in press): DOI: 10.1080/13543784.2019.156185.
  • 24. Immunotherapy and Cannabis • Retrospective review of nivolumab-treated patients at Ramban Health Care Campus; Haifa, Israel • N=140 patients (nivolumab, 89; nivolumab + cannabis, 51) • Advanced melanoma, non-small cell lung cancer, renal cell carcinoma • Results – Cannabis only factor which reduced reduced response rate (nivolumab, 37%; combination, 15.9% – Cannabis did not affect overall or progression-free survival Taha T, et al. Ann Oncol. 2017;28(5):1545PD.
  • 26. Nausea and Vomiting • 30 studies published – Smoked THC – Synthetic cannabinoids – Nabiximols • Meta-analysis found compared with placebo – Significantly more effective for nausea and vomiting • Not evaluated with current antiemetic regimens
  • 27. Cancer-Associated Pain Study Design Patients Therapy Results Noyes 1975 RCT/DB/PC Cancer pain N=10 Dronabinol 5mg, 10mg 15mg and 20mg vs placebo 15 and 20 mg - substantial analgesic effects; antiemesis and appetite stimulation; 20 mg = 120 mg codeine Johnson 2010 RCT/DB/PC Cancer pain N=177 Nabiximols vs THC 2.7 mg oromucosal spray vs placebo • Significantly improved mean pain score; > 30% reduction in pain from baseline score for THC/CBD product • No change for THC product • No change in mean opioid dose or breakthrough doses Portenoy 2012 RCT/DB/PC Cancer pain N=360 Nabiximols (low, medium, high dose) vs placebo • Better pain control and sleep disruption with low dose compared with placebo • Adverse events dose related Lynch 2014 RCT/PC CIN N=16 Nabiximols vs placebo • No statistical difference on numeric pain rating • 5 responders decreased 2.6 on 11-pt scale CBD, cannabidiol; DB, double-blind; PC, placebo-controlled; RCT, randomized controlled trial; THC, delta-9-tetrahydrocannabinoid. Noyes R, et al. Clin Pharmacol Therp. 1975;18;84-89; Noyes R, et al. J Clin Pharmacol. 1975;15:139-143; Johnson JR, et al. J Symptom Manage. 2010;39:167-178; Portenoy RK, et al. J Pain. 2012;13:438-449; Lynch ME, et al. J Symptom Manage. 2014;47:166- 173.
  • 28. Anorexia/Weight Gain • Appetite increase: 49% • Weight gain: 3%Dronabinol 2.5 mg po BID + placebo • Appetite increase: 75% (P=.0001) • Weight gain: 11% (P=.02) • Improved QOL and toxicity Megestrol 800 mg po daily + placebo • Appetite increase: 66% (P=.17) • Weight gain: 8% (P=.43) Dronabinol 2.5 mg BID + Megestrol 800 mg po daily Randomized, double-blind, parallel group N=469 Advanced cancer Weight loss QOL, quality of life. Jatoi A, et al. J Clin Oncol. 2002;20:567-573; Strasser F, et al . J Clin Oncol. 2006;24:3394-3400.
  • 29. Anorexia & Cachexia Increased appetite: • Cannabis extract: 73% • THC: 58% • Placebo: 69% No significant differences in: • Appetite • QOL • Toxicity Cannabis extract (THC 2.5 mg CBD: 1 mg) (n=66) THC 2.5 mg (n=65) Adult patients Advanced cancer Cancer-related anorexia and/or cachexia ECOG PS < 2 R A N D O M I Z E D 2:2:1 ECOG, Eastern Cooperative Oncology Group; CBD, cannabidiol; THC, delta-9- tetrahydrocannabinoid. Strasser F, et al. J Clin Oncol. 2006;24:3394-3400. Placebo (n=33)
  • 30. Cannabinoids for Insomnia • Meta-analysis of 19 placebo-controlled studies – Cannabis-products evaluated for other indications and evaluated sleep – Nabiximols: 13 studies – THC/CBD capsules: 2 studies – Smoked THC: 2 studies – Dronabinol: 1 study – Nabilone: 1 study • Greater average improvement in – Sleep quality – Sleep disturbance CBD, cannabidiol; CI, confidence interval; THC, delta-9-tetrahydrocannabinoid. Whiting PF, et al. JAMA. 2015;313:2456-2473.
  • 31. Depression and Anxiety • No studies specific in cancer patients • Meta-analyses of indications – No well designed trials evaluating depression – Depression as an outcome: no difference found compared with placebo – Positive for individuals with social anxiety and anxiety in chronic pain patients Whiting PF, et al. JAMA. 2015;313:2456-2473.
  • 32. Adverse Effects of Cannabis-Based Medications Most Common Common Rare Drowsiness/fatigue Euphoria Orthostatic hypotension Dizziness Blurred vision Toxic psychosis/paranoia Dry mouth Headache Depression Cough/phlegm/ bronchitis (smoking only) Ataxia/dyscoordination Anxiety Tachycardia (after titration) Nausea Hyperemesis Cognitive effects Diarrhea MacCallum CA, et al. Eur J Inter Med. 2018;49:12-19. • Schizophrenia/bipolar disorder, long-term cognitive dysfunction
  • 33. COMPASS Study •Nonserious AEs: 88.4% vs 85.2% •Cannabis: nervous system, GI, respiratory •Serious adverse effects: 13% (cannabis) vs 19% •Deaths: 0% vs 1% Primary objective Assess risk of adverse events •No significant change in pulmonary function tests •No difference in neurocognition at 1 year •No changes in liver, renal, or endocrine labs •Significant reduction in average pain intensity at 1 yr: change, 0.92 vs 0.18 •QOL; 2.36 points greater with cannabis Secondary objective Pulmonary function Neurocognitive function Other safety Effect on pain and QOL AE; adverse events; QOL, quality of life; THC; delta-9-tetrahydrocannabinoid. Ware MA, et al. J Pain. 2015;16:1233-1241. Prospective, cohort study Jan 2004-April 2008 Adults chronic non-cancer pain using cannabis (12.5% THC), any delivery system vs control population
  • 34. Cannabinoid Hyperemesis Syndrome • Recurrent paroxysmal episodes of nausea/vomiting in chronic users • Mitigated by frequent hot bathing/showering • Complications: acute renal failure, electrolyte depletion, pnuemomediastinum • Acute treatment – Replace fluids – Medications • Antiemetic • Anxiolytics • Antiphsycotics • Capsaicin topical – Hot showers • Long-term treatment – Stop cannabis use N/V nausea and vomiting; 5HT3; 5-hydroxytryptamin or serotonin. Richards JR, et al. Pharmacother. 2017;37:725-734; Health Canada. https://www.canada.ca/content/dam/hc-sc/documents/services/drugs- medication/cannabis/information-medical-practitioners/information-health-care-professionals- cannabis-cannabinoids-eng.pdf. Accessed March 24, 2019.
  • 35. Contraindications • Allergy to any cannabinoid • Past history of psychotic disorder • Active or unstable cardiovascular disease Caution • Pregnant or nursing women • Potential for dependence/abuse • Driving Canadian Consortium for the Investigation of Cannabinoids. Available at www.ccic.net. Accessed March 24, 2019.
  • 36. Now That You Have the Evidence….
  • 37. What are Legal Implications? State laws allow US Dept Justice stance Patient benefits Schedule I Institution stance Medical association stance Hill. JAMA. 2015;313:2474-2480.
  • 38. When to Use? • Qualifying condition • Multiple failed trials of first- and second-line pharmacotherapies • Failed trial of FDA approved cannabinoid • No active substance, psychiatric, unstable mood or anxiety disorder Hill. JAMA. 2015;313:2474-2480.
  • 39. State Medical Marijuana Programs • Provider certifies patient with qualifying condition • Patient registers, some states allow caregivers • Go to dispensary to purchase product Department of Consumer Protection Medical Marijuana Program. Available at: https://portal.ct.gov/DCP/Medical-Marijuana-Program/Medical-Marijuana- Statistics. Accessed March 24, 2019.
  • 40. CT Qualifying Conditions - Adults Amyotrophic lateral sclerosis HIV/AIDS Post herpetic neuralgia Cachexia Intractable HA syndrome Psoriasis (severe) Cancer Multiple sclerosis Psoriatic arthritis Cerebral palsy Muscular dystrophy Rheumatoid arthritis severe Complex regional pain syndrome Hydrocephalus with intractable HA Terminal illness requiring end- of-life care Crohn’s disease Neuropathic facial pain Sickle cell disease Cystic fibrosis Osteogenesis imperfecta Ulcerative colitis Epilepsy Parkinson disease Uncontrolled intractable seizure disorder Glaucoma PTSD Wasting syndrome Damage to spinal cord with intractable spasticity or irreversible cord injury Fibromyalgia (spasticity/neuropathic pain) Post laminectomy syndrome with chronic radiculopathy Department of Consumer Protection Medical Marijuana Program. Available at: https://portal.ct.gov/DCP/Medical-Marijuana-Program/Qualification- Requirements. Accessed March 24, 2019.
  • 41. CT Qualifying Conditions - Children Cerebral palsy Cystic fibrosis Irreversible spinal cord injury with objective neurological indication of intractable spasticity Muscular dystrophy Osteogenesis imperfecta Severe epilepsy Terminal illness requiring end-of-life care Uncontrolled intractable seizure disorder Department of Consumer Protection Medical Marijuana Program. Available at: https://portal.ct.gov/DCP/Medical-Marijuana-Program/Qualification- Requirements. Accessed March 24, 2019
  • 42. Dispensaries in CT • CT licensed pharmacists • Similar restrictions/requirements as pharmacy • Security system • Qualified patients and caregivers allowed in facility • No compounding • Review PMP Department of Consumer Protection Medical Marijuana Program. Available at: https://portal.ct.gov/DCP/Medical-Marijuana-Program/Dispensary-Facility. Accessed March 24, 2019.
  • 43. Dispensary Pharmacist’s Role • Complete an initial patient assessment – What symptoms require relief? – Naïve vs experienced user – Patient’s lifestyle • Help patient select product – Strain, dosage form, delivery device – Variations on time to effect, adverse effects • Equip patient with tools to self- assess efficacy of product • Report any adverse events that may occur
  • 44. Medical Marijuana in Hospitals • Pharmacologic implications • Legal challenges • Federal compliance for funding/licensure • Acquisition of product • Other considerations – No smoking policy – Training – Monitoring/outcomes • Typical policies – Not allowed for inpatients
  • 45. How Your Healthcare Provider Should Monitor Your Use • Changes in – Medical condition/symptoms – Physical or psychosocial function – Medication list • Efficacy of treatment • Adverse effects • Liver function tests? • Safety of use (possible diversion, driving/equipment use) • Goals of treatment • Progress towards goals Medical Board of California. Available at: https://www.mbc.ca.gov/Publications/guidelines_cannabis_recommendation.pdf. Accessed 6 January 2019; Epidiolex [package insert]. Carlsbad, CA: Greenwich Biosciences, Inc: 2018..
  • 46. What You Need To Know • Registration process • Variability of quality and concentration of cannabis • Dosing and dosage forms (start low and go slow) • Potential risks of cannabis – Adverse effects – Pregnancy/lactation – Drug interactions • Financing, travel • Safeguards to prevent diversion • Symptom inventory chart Medical Board of California. Available at: https://www.mbc.ca.gov/Publications/guidelines_cannabis_recommendation.pdf. Accessed 6 January 2019.
  • 47. Summary • THC and CBD are primarily responsible for medicinal effects • Limited data supports medical marijuana use in cancer and associated symptoms; yet many patients have benefit. This may be due to the lack of well designed studies • Most side effects are transient and can be treated by adjusting doses • Patient certification process can be facilitated by dispensary staff
  • 48. Resources • Centers for Disease Control: https://www.cdc.gov/marijuana/index.htm • NIH: https://nccih.nih.gov/health/marijuana • Health Canada: https://www.canada.ca/en/health- canada/topics/cannabis-for-medical- purposes.html
  • 50. Q & A SNAP A #STRONGARMSELFIE In 2018, up to $55,000 will be donated thanks to our sponsors: Bayer, Fujifilm, Myriad Genetics and Taiho Oncology! Flex a “strong arm” & post it to Twitter or Instagram using the hashtag #StrongArmSelfie
  • 51. CONTACT US CALL TOLL FREE 1.877.427.2111

Editor's Notes

  1. pain
  2. PERMISSION: Need to request – found on this site: http://marijuanaindustrygroup.org/